Grand Angels Announces Seventh Investment to Wrap up Successful 2006 (back) 1/10/2007 FOR IMMEDIATE RELEASE Grand Angels Announces Seventh Investment to Wrap up Successful 2006 Holland Michigan – January 10, 2007 Accuri Cytometers, whose tagline is “Cell analysis within reach™”, is the latest addition to Grand Angels’ portfolio. The Accuri C6 Flow Cytometer™ System represents a dramatic step forward in flow cytometry and cell analysis. For the first time ever researchers have access to a full function analytical cytometer at an affordable price. Selling for just $25,000, and sized to fit on any laboratory benchtop, the C6 Flow Cytometer System makes a powerful research tool available to a much wider range of life scientists. Conventional systems can cost up to five times more. Accuri’s user-driven design has resulted in a system that offers both performance and simplicity. Combined with the intuitive CFlow™ software, Accuri’s product makes flow cytometry equally accessible to experts and new users. “We are delighted at the strong positive reception the Accuri C6 Flow Cytometer System received in its initial debut at a recent scientific meeting,” said Jennifer Baird, co-founder and CEO of Accuri. “We set out to develop a revolutionary approach designed to bring the powerful technology of flow cytometry to life sciences researchers everywhere, and we believe we have succeeded. We appreciate the support of Grand Angels and other regional institutions, which have been critical in our ability to develop this innovative technology from the ground up and in record time.” Grand Angels partnered with Plymouth Venture Partners of Ann Arbor on this investment. “It is our belief that the key to successful early stage investments in Michigan is through collaboration between Grand Angels and other angel bands and venture capital firms,” remarked Grand Angels president, Jody Vanderwel. The C6 Flow Cytometer is now in the process of being launched to the market, but life science researchers have already expressed their enthusiasm for its performance, ease of use and affordability The easy-to-use QuickStart guides tout a learning curve measured in hours compared to the traditional five-day training course for new flow cytometers. Feedback from testers range from, “You have made a quantum leap in terms of simplicity and elegant design,” to “"…Wow, that would be great! When can I get one?" Accuri is formally launching the product later this month. Concluding its third year as an angel band, Grand Angels ended 2006 on a high note. This year’s financial transactions included two initial investments, two follow-on rounds, and a profitable exit. Most of the businesses in which Grand Angels members hold a stake continue to show positive results. Companies range from a feel-good life-style brand to high-tech equipment and research to fantasy sports drafting. Green Daisy is launching a book tour to promote its publication, Mommy Millionaire; Mock Draft Central is positioning itself as the leading internet site for fantasy sports mock drafting. ProNAi is pioneering a new class of nucleic-acid drugs to treat complex genetic diseases and received $1.6M from the 21st Century Jobs Fund. Salamander Technologies doubled it revenues over 2005, and RF Identics was sold to Avery Dennison returning Grand Angels’ investment within 18 months. “We are pleased to add a medical device company to our portfolio and anticipate that Accuri will be successful in the marketplace,” added Vanderwel. Grand Angels continues to focus on early stage businesses in West Michigan and encourages entrepreneurs to visit their website ( www.grandangels.org ) for more information on how to apply for funding. Grand Angels is a regional investment group that offers mentoring paired with a relatively patient exit strategy – meaning, invested funds need not be returned as quickly as would be expected by commercial lenders. The mission of Grand Angels is to utilize its financial, intellectual and networking capital to promote the success of young growing companies and to enhance the economic development of West Michigan. Grand Angel members invest as individuals and not as a group fund. Members have invested over $3 million in seven Michigan businesses to date. ###